Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis

Rod Dawson, Rany Condos, Doris Tse et al. · 2009

Read Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis by Rod Dawson, Rany Condos, Doris Tse et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006984.txt.

Description

Rod Dawson, Rany Condos, Doris Tse, and colleagues trialled an immune booster for tuberculosis in PLOS ONE in 2009. Standard treatment for lung tuberculosis takes at least six months of therapy. A lab-made immune signal, recombinant interferon-gamma 1b, might shorten that course. It could calm lung inflammation and clear infectious sputum sooner.

The team added the booster to standard drug treatment. They then measured whether patients improved faster. Even a modest shortening would matter for tuberculosis control. Long courses are hard to finish, and unfinished courses breed drug-resistant bacteria that endanger whole communities.

Catalog record

CREATORRod Dawson, Rany Condos, Doris Tse et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006984

Browse the full library · About the Tower of Babel